APOBEC3A is a prominent cytidine deaminase in breast cancer.
APOBEC cytidine deaminases are the second-most prominent source of mutagenesis in sequenced tumors. Previous studies have proposed that APOBEC3B (A3B) is the major source of mutagenesis in breast cancer (BRCA). We show that APOBEC3A (A3A) is the only APOBEC whose expression correlates with APOBEC-in...
Main Authors: | Luis M Cortez, Amber L Brown, Madeline A Dennis, Christopher D Collins, Alexander J Brown, Debra Mitchell, Tony M Mertz, Steven A Roberts |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-12-01
|
Series: | PLoS Genetics |
Online Access: | https://doi.org/10.1371/journal.pgen.1008545 |
Similar Items
-
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
by: Iñigo Narvaiza, et al.
Published: (2009-05-01) -
Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases
by: Atsushi eKoito, et al.
Published: (2013-02-01) -
The APOBEC3B cytidine deaminase is an adenovirus restriction factor.
by: Noémie Lejeune, et al.
Published: (2023-02-01) -
Human APOBEC1 cytidine deaminase edits HBV DNA
by: Wain-Hobson Simon, et al.
Published: (2009-10-01) -
Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase.
by: Rodolphe Suspène, et al.
Published: (2013-01-01)